(Q21245663)

English

IMP321 (sLAG-3), an immunopotentiator for T cell responses against a HBsAg antigen in healthy adults: a single blind randomised controlled phase I study

scientific article

In more languages

Statements

scholarly article

0 references

IMP321 (sLAG-3), an immunopotentiator for T cell responses against a HBsAg antigen in healthy adults: a single blind randomised controlled phase I study (English)

0 references

author name string

Chrystelle Brignone

1

author given names

Chrystelle

author last names

Brignone

1 reference

Dimensions Publication ID

19 August 2022

Caroline Grygar

2

author given names

Caroline

author last names

Grygar

1 reference

Dimensions Publication ID

19 August 2022

Manon Marcu

3

author given names

Manon

author last names

Marcu

1 reference

Dimensions Publication ID

19 August 2022

Gaëlle Perrin

4

author given names

Gaëlle

author last names

Perrin

1 reference

Dimensions Publication ID

19 August 2022

Frédéric Triebel

5

author given names

Frédéric

author last names

Triebel

1 reference

Dimensions Publication ID

19 August 2022

language of work or name

0 references

publication date

2007

0 references

Journal of immune based therapies and vaccines

1 reference

5

0 references

1

0 references

5

0 references

https://scigraph.springernature.com/pub.10.1186/1476-8518-5-5

0 references

Soluble human LAG-3 molecule amplifies the in vitro generation of type 1 tumor-specific immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852106

12 September 2017

Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852106

12 September 2017

Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852106

12 September 2017

Soluble CD40 ligand induces β 3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852106

12 September 2017

MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852106

12 September 2017

LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852106

12 September 2017

MHC class II engagement by its ligand LAG-3 (CD223) leads to a distinct pattern of chemokine and chemokine receptor expression by human dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852106

12 September 2017

Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852106

12 September 2017

A soluble lymphocyte activation gene-3 molecule used as a vaccine adjuvant elicits greater humoral and cellular immune responses to both particulate and soluble antigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852106

12 September 2017

Lymphocyte activation gene-3 induces tumor regression and antitumor immune responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852106

12 September 2017

T cell major histocompatibility complex class II molecules down-regulate CD4+ T cell clone responses following LAG-3 binding

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852106

12 September 2017

Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or After HBs vaccination: Stimulation of thein vitroantibody response by interferon gamma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1852106

29 November 2018

CpG-A and CpG-B oligonucleotides differentially enhance human peptide-specific primary and memory CD8+ T-cell responses in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/17394654

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17394654

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17394654

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant

1 reference

https://pubmed.ncbi.nlm.nih.gov/17394654

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1476-8518-5-5

0 references

Dimensions Publication ID

0 references

release_a3abdztmzvaxfp4obrsrxiy7vm

0 references

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q21245663&oldid=1707694897"